Dr. Thierry Alcindor
Claim this profileMcGill University
Studies Giant Cell Tumor
Studies Tumors
5 reported clinical trials
13 drugs studied
Affiliated Hospitals
Clinical Trials Thierry Alcindor is currently running
Tazemetostat + Doxorubicin
for Sarcoma
The participants of this study will have advanced epithelioid sarcoma. Sarcoma is a cancer of the connective tissues, such as nerves, muscles and bones. Epithelioid sarcoma is an ultra-rare sarcoma of the soft-tissue. Part 1 of this trial will evaluate the safety and the level of the study drug that the study drug combinations can be tolerated (known as tolerability). It is also designed to establish a recommended study drug dosage for the next part of the study. Part 2 will evaluate and compare for each of the study drug combinations how long participants live without their disease getting worse. The study drug is called tazemetostat. The study will test tazemetostat in combination with doxorubicin compared to placebo (dummy treatment) in combination with doxorubicin. Doxorubicin is a current front line treatment for epithelioid sarcoma
Recruiting1 award Phase 312 criteria
Tamibarotene + Azacitidine
for Myelodysplastic Syndrome
This study compares the efficacy of Tamibarotene in combination with azacitidine to azacitidine in combination with placebo in participants who are Retinoic Acid Receptor Alpha (RARA) positive, and newly diagnosed with higher-risk myelodysplastic syndrome (HR-MDS), and who have not received treatment for this diagnosis. The primary goal of the study is to compare the complete remission rate between the two treatment arms.
Recruiting1 award Phase 34 criteria
More about Thierry Alcindor
Clinical Trial Related3 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Thierry Alcindor has experience with
- Tamibarotene
- Azacitidine
- Trastuzumab
- Trastuzumab Placebo
- Tucatinib
- Tucatinib Placebo
Breakdown of trials Thierry Alcindor has run
Pigmented Villonodular Synovitis
Tenosynovial Giant Cell Tumor
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Thierry Alcindor specialize in?
Thierry Alcindor focuses on Giant Cell Tumor and Tumors. In particular, much of their work with Giant Cell Tumor has involved Stage IV patients, or patients who are undergoing treatment.
Is Thierry Alcindor currently recruiting for clinical trials?
Yes, Thierry Alcindor is currently recruiting for 2 clinical trials in Montreal Quebec. If you're interested in participating, you should apply.
Are there any treatments that Thierry Alcindor has studied deeply?
Yes, Thierry Alcindor has studied treatments such as Tamibarotene, Azacitidine, Trastuzumab.
What is the best way to schedule an appointment with Thierry Alcindor?
Apply for one of the trials that Thierry Alcindor is conducting.
What is the office address of Thierry Alcindor?
The office of Thierry Alcindor is located at: McGill University Department of Oncology / McGill University Health Centre, Montreal, Quebec H4A 3J1 Canada. This is the address for their practice at the McGill University Department of Oncology / McGill University Health Centre.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.